Literature DB >> 14635157

Measurement of single-kidney glomerular filtration rate using a contrast-enhanced dynamic gradient-echo sequence and the Rutland-Patlak plot technique.

Nils Hackstein1, Jan Heckrodt, Wigbert S Rau.   

Abstract

PURPOSE: To determine the accuracy of single-kidney glomerular filtration rate (GFR) determination using contrast-enhanced dynamic magnetic resonance imaging (MRI) and the Rutland-Patlak plot technique.
MATERIALS AND METHODS: Twenty-eight adult patients were included. As reference method, the GFR was measured by plasma clearance using a small bolus injection of iopromide. A three-dimensional gradient-echo (GRE) sequence with a flip angle of 50 degrees was used for MRI; this showed a good linear relationship between gadolinium (Gd)-DTPA concentration and signal change when measured up to a Gd-DTPA concentration of 10 mmol/liter. A slab containing both kidneys and the abdominal aorta was measured 30 times in approximately 3.5 minutes. During this measurement, 15 mL of Gd-DTPA, 0.5 mol/liter diluted to a volume of 60 mL, was injected over 60 seconds. A Rutland-Patlak plot was calculated from the signal changes in the aorta and the renal parenchyma. Single-kidney GFR was calculated for different time windows from the Rutland-Patlak plot slope.
RESULTS: The best correlation compared to the reference method was found with the GFR calculated from the slope of the Rutland-Patlak plot 40-110 seconds postaortic rise. Pearson's correlation coefficient was r = 0.86, SD was 14.8 mL/minute. In many of the patients, a decrease of the renal signal was observed in the excretory phase, which was probably caused by very high Gd-DTPA concentrations in the collecting tubules.
CONCLUSION: Single-kidney GFR can be calculated from dynamic contrast-enhanced MRI. We found a promising correlation of global GFR calculated by MRI compared to the reference method. In any future study, the amount of Gd-DTPA should by reduced to avoid artificial signal drop in the excretory phase induced by the T2* effect. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14635157     DOI: 10.1002/jmri.10410

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  39 in total

1.  Joint segmentation and groupwise registration of cardiac perfusion images using temporal information.

Authors:  Dwarikanath Mahapatra
Journal:  J Digit Imaging       Date:  2013-04       Impact factor: 4.056

Review 2.  Obstructive diseases of the urinary tract in children: lessons from the last 15 years.

Authors:  Michael Riccabona
Journal:  Pediatr Radiol       Date:  2010-04-30

Review 3.  Pediatric uroradiology: state of the art.

Authors:  Kassa Darge; J Damien Grattan-Smith; Michael Riccabona
Journal:  Pediatr Radiol       Date:  2010-04-21

Review 4.  [Functional magnetic resonance imaging of the kidneys].

Authors:  R S Lanzman; M Notohamiprodjo; H J Wittsack
Journal:  Radiologe       Date:  2015-12       Impact factor: 0.635

Review 5.  MR urography in children.

Authors:  J Damien Grattan-Smith; Richard A Jones
Journal:  Pediatr Radiol       Date:  2006-06-22

Review 6.  Analysis of contrast-enhanced MR images to assess renal function.

Authors:  N Michoux; J-P Vallée; A Pechère-Bertschi; X Montet; L Buehler; B E Van Beers
Journal:  MAGMA       Date:  2006-08-12       Impact factor: 2.310

7.  Modeling systemic and renal gadolinium chelate transport with MRI.

Authors:  John R Votaw; Diego Martin
Journal:  Pediatr Radiol       Date:  2007-12-11

Review 8.  Urinary tract imaging in infancy.

Authors:  Michael Riccabona
Journal:  Pediatr Radiol       Date:  2009-06

9.  MR urography in children: how we do it.

Authors:  J Damien Grattan-Smith; Stephen B Little; Richard A Jones
Journal:  Pediatr Radiol       Date:  2007-12-11

Review 10.  Renal relevant radiology: renal functional magnetic resonance imaging.

Authors:  Behzad Ebrahimi; Stephen C Textor; Lilach O Lerman
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-26       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.